General and central obesity, combined oral contraceptive use and hypertension in chinese women

American Journal of Hypertension

Volumn 24, Issue 12, 2011, Pages 1324-1330

  Wang, Chun ^a,b,c   Li, Ying ^a,b,d   Bai, Jianling ^a   Qian, Weichong ^e   Zhou, Jian ^b,d   Sun, Zhiming ^b,d   Ba, Lei ^b,d   Wei, Wei ^f   Li, Huiqiao ^a   Sun, Tao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Institute of Planned Parenthood Research   (China)

^c NANTONG UNIVERSITY   (China)

^d NPFPC Contraceptives Adverse Reaction Monitoring Center   (China)

^e THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^f The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

Author keywords

blood pressure; body mass index; combined oral contraceptives; hypertension; waist circumference

Indexed keywords

APOLIPOPROTEIN; LIPID; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CHINA; CHINESE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

APOLIPOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEINS; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; PREVALENCE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 81155152344     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.157     Document Type: Article

References (33)

1. Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L, Chen C. Economic burden of obesityrelated chronic diseases in Mainland China. Obes Rev 2008; 9 Suppl 1:62-67. (Pubitemid 351643192)
2. Chen CM. Overview of obesity in Mainland China. Obes Rev 2008; 9 Suppl 1:14-21. (Pubitemid 351643185)
3. Du SM, Ma GS, Li YP, Fang HY, Hu XQ, Yang XG, Hu YH. Relationship of body mass index, waist circumference and cardiovascular risk factors in Chinese adult. Biomed Environ Sci 2010; 23:92-101.
4. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. Eur J Clin Nutr 2010; 64:16-22.
5. Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010; 64:2-5.
6. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X; China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118:2679-2686.
7. Ying X, Song ZY, Zhao CJ, Jiang Y. Body mass index, waist circumference, and cardiometabolic risk factors in young and middle-aged Chinese women. J Zhejiang Univ Sci B 2010; 11:639-646.
8. Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009; 53:221-231.
9. Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, Curhan G, Colditz GA, Stampfer MJ. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996; 94:483-489. (Pubitemid 26266136)
10. Dong W, Colhoun HM, Poulter NR. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994. J Hypertens 1997; 15:1063-1068. (Pubitemid 27420386)
11. Edelman AB, Carlson NE, Cherala G, Munar MY, Stouffer RL, Cameron JL, Stanczyk FZ, Jensen JT. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 2009; 80:119-127.
12. Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003; 89:493-498. (Pubitemid 36329240)
13. Sidney S, Petitti DB, Soff GA, Cundiff DL, Tolan KK, Quesenberry CP Jr. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 2004; 70:3-10. (Pubitemid 38781972)
14. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139:289-296. (Pubitemid 47493087)
15. Higginbotham S; Society of Family Planning. Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091. Contraception 2009; 80:583-590.
16. Li Y, Zhou L, Coulter D, Gao E, Sun Z, Liu Y, Wang X. Prospective cohort study of the association between use of low-dose oral contraceptives and stroke in Chinese women. Pharmacoepidemiol Drug Saf 2006; 15:726-734. (Pubitemid 44649511)
17. Wei W, Li Y, Chen F, Chen C, Sun T, Sun Z, Wu Y, Zhou J, Ba L. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens 2011; 25:364-371.
18. Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010; 9:45.
19. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358:910-919. (Pubitemid 351397090)
20. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-1649. (Pubitemid 41552419)
21. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376:112-123.
22. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waistto-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28:850-856. (Pubitemid 47343598)
23. Nyamdorj R, Qiao Q, Lam TH, Tuomilehto J, Ho SY, Pitkäniemi J, Nakagami T, Mohan V, Janus ED, Ferreira SR; Decoda Study Group. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity (Silver Spring) 2008; 16:1622-1635. (Pubitemid 351915134)
24. Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, Janus E, Caterson I, Zimmet P, Prabhakaran D, Reddy S, Woodward M; Obesity in Asia Collaboration. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008; 9 Suppl 1:53-61. (Pubitemid 351643191)
25. Chuang SY, Chou P, Hsu PF, Cheng HM, Tsai ST, Lin IF, Chen CH. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens 2006; 19:788-795. (Pubitemid 44107694)
26. The ESHRE Capri Workshop Group. Hormones and cardiovascular health in women. Hum Reprod Update 2006; 12:483-497.
27. Dinger JC, Heinemann LA, Kühl-Habich D. The safety of a drospirenonecontaining oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007; 75:344-354. (Pubitemid 46551071)
28. Skouby SO. Hormonal contraception in obesity, the metabolic syndrome, and diabetes. Ann N Y Acad Sci 2010; 1205:240-244.
29. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009; 123 Suppl 4:S11-S17.
30. Colin Bell A, Adair LS, Popkin BM. Ethnic differences in the association between body mass index and hypertension. Am J Epidemiol 2002; 155:346-353. (Pubitemid 34132053)
31. Gallo MF, Grimes DA, Schulz KF, Helmerhorst FM. Combination estrogenprogestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol 2004; 103:359-373.
32. Cheung BM, Ong KL, Tso AW, Leung RY, Xu A, Cherny SS, Sham PC, Lam TH, Lam KS. C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort. J Hum Hypertens, in press.
33. Kwok S, Canoy D, Ashton WD, Lowe GD, Wood D, Humphries SE, Charlton-Menys V, Durrington PN. Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: the United Kingdom Women's Heart Study (UKWHS). Clin Endocrinol (Oxf ) 2009; 71:727-732.